Dr Sud Speaks, page-28

GW pharma's business is from seed thru development and sales. So is a bit different to IHL.

I have owned GW for a couple of years with an average price now of $US 96 per share. I have seen it rise to over $US 140 and now sit at $ Us 109. Yes they sell the only FDA approved CBD medication. But their research into and extraction sceince of this plant is incredible.

I only hold three medical cannabis companies, and have pretty much equal holdings in all of them. IHL and GW are two of them.